Profund Advisors LLC lowered its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 2.9% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 12,977 shares of the company’s stock after selling 390 shares during the period. Profund Advisors LLC’s holdings in Henry Schein were worth $907,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors also recently bought and sold shares of HSIC. Ibex Wealth Advisors bought a new position in Henry Schein in the 2nd quarter valued at approximately $40,000. Janney Montgomery Scott LLC lifted its position in Henry Schein by 89.7% in the 2nd quarter. Janney Montgomery Scott LLC now owns 24,882 shares of the company’s stock valued at $1,739,000 after acquiring an additional 11,768 shares in the last quarter. Toronto Dominion Bank lifted its position in Henry Schein by 0.5% in the 2nd quarter. Toronto Dominion Bank now owns 106,298 shares of the company’s stock valued at $7,428,000 after acquiring an additional 548 shares in the last quarter. Tyers Asset Management LLC lifted its position in Henry Schein by 6.7% in the 1st quarter. Tyers Asset Management LLC now owns 59,584 shares of the company’s stock valued at $3,582,000 after acquiring an additional 3,744 shares in the last quarter. Finally, Clal Insurance Enterprises Holdings Ltd bought a new position in Henry Schein in the 1st quarter valued at approximately $1,202,000.
Several equities analysts recently issued reports on HSIC shares. Zacks Investment Research cut Henry Schein from a “buy” rating to a “hold” rating and set a $76.00 price objective on the stock. in a research report on Wednesday, June 19th. William Blair cut Henry Schein from an “outperform” rating to a “market perform” rating in a research report on Wednesday, August 7th. TheStreet cut Henry Schein from a “b” rating to a “c+” rating in a research report on Friday, August 30th. BidaskClub raised Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, September 12th. Finally, Barrington Research reaffirmed a “buy” rating and issued a $75.00 price objective on shares of Henry Schein in a research report on Wednesday, August 7th. Six equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $73.64.
Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $0.84 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.83 by $0.01. Henry Schein had a return on equity of 16.67% and a net margin of 4.18%. The business had revenue of $2.45 billion during the quarter, compared to analyst estimates of $2.48 billion. During the same quarter in the prior year, the business posted $1.04 EPS. Henry Schein’s revenue for the quarter was up 5.7% compared to the same quarter last year. On average, analysts predict that Henry Schein, Inc. will post 3.46 earnings per share for the current year.
In other news, EVP Gerald A. Benjamin sold 19,630 shares of the firm’s stock in a transaction dated Wednesday, June 19th. The stock was sold at an average price of $72.02, for a total transaction of $1,413,752.60. Following the completion of the transaction, the executive vice president now owns 113,832 shares in the company, valued at $8,198,180.64. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Vice Chairman James P. Breslawski sold 6,856 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $60.17, for a total value of $412,525.52. Following the transaction, the insider now owns 249,046 shares of the company’s stock, valued at approximately $14,985,097.82. The disclosure for this sale can be found here. Insiders sold a total of 47,198 shares of company stock valued at $3,321,063 in the last quarter. 1.06% of the stock is currently owned by company insiders.
About Henry Schein
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Story: How to calculate the intrinsic value of a stock
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.